Phase II multicenter study to evaluate the efficacy and safety of Tarceva (TM) (erlotinib, OSI-774) in women with previously treated locally advanced or metastatic breast cancer Meeting Abstract


Authors: Winer, E.; Cobleigh, M.; Dickler, M.; Miller, K.; Fehrenbacher, L.; Jones, C.; Justice, R.
Abstract Title: Phase II multicenter study to evaluate the efficacy and safety of Tarceva (TM) (erlotinib, OSI-774) in women with previously treated locally advanced or metastatic breast cancer
Meeting Title: 25th Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Breast Cancer Research and Treatment
Volume: 76
Issue: Suppl. 1
Meeting Dates: 2002 Dec 11-14
Meeting Location: San Antonio, TX
ISSN: 0167-6806
Publisher: Springer  
Date Published: 2002-12-01
Start Page: S115
Language: English
ACCESSION: WOS:000179770100341
PROVIDER: wos
DOI: 10.1023/A:1021560101414
PUBMED: 12516550
Notes: Meeting Abstract: 445 -- 25th San Antonio Breast Cancer Symposium -- DEC 11-14, 2002 -- SAN ANTONIO, TEXAS -- 1 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maura N Dickler
    263 Dickler